Study of PI-88 in Patients With Advanced Melanoma
NCT00068172
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
DRUG:
PI-88
Sponsor
Cellxpert Biotechnology Corp.
Collaborators
[object Object]